79 related articles for article (PubMed ID: 33909674)
21. Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.
Marshall-Webb M; Bright T; Price T; Thompson SK; Watson DI
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27878904
[TBL] [Abstract][Full Text] [Related]
22. Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review.
Moufarrij S; Sassine D; Basaran D; Jewell EL
Gynecol Oncol; 2023 Mar; 170():167-171. PubMed ID: 36701837
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Cho YK; Kim YB
BMC Cancer; 2021 Oct; 21(1):1166. PubMed ID: 34717579
[TBL] [Abstract][Full Text] [Related]
25. Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea.
Shin W; Lee S; Lim MC; Jung J; Kim HJ; Cho H
Cancer Med; 2021 Mar; 10(6):2045-2053. PubMed ID: 33638309
[TBL] [Abstract][Full Text] [Related]
26. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
[TBL] [Abstract][Full Text] [Related]
27. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
[TBL] [Abstract][Full Text] [Related]
28. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
[TBL] [Abstract][Full Text] [Related]
29. Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
Trugilho IA; Renni MJP; Medeiros GC; Thuler LCS; Bergmann A
Thromb Res; 2020 Jan; 185():49-54. PubMed ID: 31759190
[TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.
Kahr HS; Christiansen OB; Grove A; Iyer V; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
Thromb Res; 2019 Sep; 181():112-119. PubMed ID: 31400621
[TBL] [Abstract][Full Text] [Related]
31. Socioeconomic inequalities in obesity among Korean women aged 19-79 years: the 2016 Korean Study of Women's Health-Related Issues.
Choi E; Cho HN; Seo DH; Park B; Park S; Cho J; Kim S; Park YR; Choi KS; Rhee Y
Epidemiol Health; 2019; 41():e2019005. PubMed ID: 30917463
[TBL] [Abstract][Full Text] [Related]
32. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
Manning-Geist BL; Alimena S; Del Carmen MG; Goodman A; Clark RM; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
Gynecol Oncol; 2019 Apr; 153(1):63-67. PubMed ID: 30635213
[TBL] [Abstract][Full Text] [Related]
33. Venous thromboembolism in patients with cancer undergoing surgical exploration.
Ruff SM; Weber KT; Khader A; Conte C; Kadison A; Sullivan J; Wang J; Zaidi R; Deutsch GB
J Thromb Thrombolysis; 2019 Feb; 47(2):316-323. PubMed ID: 30560488
[TBL] [Abstract][Full Text] [Related]
34. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.
Wagner BE; Langstraat CL; McGree ME; Weaver AL; Sarangi S; Mokri B; Dowdy SC; Cliby WA; Kumar A; Bakkum-Gamez JN
Gynecol Oncol; 2019 Feb; 152(2):286-292. PubMed ID: 30471900
[TBL] [Abstract][Full Text] [Related]
35. Cancer statistics, 2018.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949
[TBL] [Abstract][Full Text] [Related]
36. Venous Thromboembolism in Gynecological Malignancy.
Cohen A; Lim CS; Davies AH
Int J Gynecol Cancer; 2017 Nov; 27(9):1970-1978. PubMed ID: 28930804
[TBL] [Abstract][Full Text] [Related]
37. Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.
Kuk A; Magnowska M; Suchy W; Swierczynska J; Zaborowski MP; Gaca M; Nowak-Markwitz E
Target Oncol; 2017 Aug; 12(4):495-503. PubMed ID: 28580507
[TBL] [Abstract][Full Text] [Related]
38. Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.
Graul A; Latif N; Zhang X; Dean LT; Morgan M; Giuntoli R; Burger R; Kim S; Ko E
Int J Gynecol Cancer; 2017 Mar; 27(3):581-587. PubMed ID: 28187092
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
